Política de privacidad de las plataformas digitales de la FMH
INTRODUCTION
Thank you for visiting our Websites and Platforms and reviewing our Privacy Policy, as well as our personal information and privacy practices.
The World Federation of Hemophilia (hereinafter "the WFH" or "WFH") recognizes that privacy is everyone's business and takes the confidentiality and security of your personal information very seriously. For this reason, we have taken steps to ensure that any personal information we collect about you is protected by a range of rigorous procedures and security measures to ensure that your information is kept confidential and used only for the purposes detailed in this Policy, unless otherwise authorized by law.
WFH is committed to protecting the privacy of all individuals about whom it collects personal information. To this end, this policy aims to establish responsible and transparent practices for the management of personal information, and to meet the requirements of the rules established by the Act Respecting the Protection of Personal Information in the Private Sector ("ARPPIPS", CQLR c. P-39.1) and the Personal Information Protection and Electronic Documents Act ("PIPEDA", S.C. 2000, c. 5) (hereinafter the "Acts"). WFH is also subject to the provisions of the European General Data Protection Regulation ("GDPR").
1.PURPOSE
2.SCOPE
3.DEFINITION OF "PERSONAL INFORMATION"
4.RESPONSIBILITIES OF WFH
5.HOW DO WE COLLECT YOUR CONSENT?
6.WHY WE COLLECT PERSONAL INFORMATION
7.WHAT PERSONAL INFORMATION DO WE COLLECT?
8.USE OF COOKIES
9.RESPONSE TO JOB OFFERS
10.PROTECTION OF THE PRIVACY OF MINORS
11.DO WE DISCLOSE YOUR PERSONAL INFORMATION TO THIRD PARTIES?
12.SHARING PERSONAL INFORMATION OUTSIDE QUÉBEC
13.HOW DO WE PROTECT YOUR PERSONAL INFORMATION?
14.RETENTION AND DESTRUCTION OF PERSONAL INFORMATION
15.ACCESSING, CORRECTING, DE-INDEXING AND PORTABILITY OF YOUR PERSONAL INFORMATION
16.WITHDRAWING YOUR CONSENT
17.CHANGES TO OUR PRIVACY POLICY
18.CONTACT DETAILS FOR THE PRIVACY OFFICER
APPENDIX A
1.
PURPOSE
1.1
This WFH Digital Platforms Privacy Policy (hereinafter "Policy" or "Privacy Policy") explains not only how we collect, use, disclose and store any information related to your personal data when you visit any Website (or "Websites") or mobile applications ("Applications" or "Platforms") operated by WFH, but also how you can access, update or take control of your personal information.
1.2
This Policy replaces and updates the WFH Website Privacy Policy (IT 003).
2.
SCOPE
2.1
This Policy generally applies to:
any personal information of a factual or subjective nature about an identifiable individual collected through the Websites and/or Platforms on which this Policy is posted, or through any other interactions you may have with us;
WFH staff members (regular employees, temporary employees and contractual resources) and senior management who handle personal information held by WFH;
visitors to our Websites and/or Platforms, our volunteers and Board members, and any person or company acting for or on behalf of WFH.
2.2
External links. This Policy does not apply to links to third-party websites, plug-ins, services, social networks or applications, including those offered via hyperlinks displayed on our Websites and/or Platforms. If you follow a link to a third-party website or use a third-party plug-in, please note that these third parties have their own privacy policies and we do not accept any responsibility or liability for those policies. We do not control these third-party websites and encourage you to read the privacy policy of each site you visit before providing them with any personal information.
3.
DEFINITION OF "PERSONAL INFORMATION"
3.1
When used in this Privacy Policy, “personal information” means any information about an individual that can be used to identify an individual, including, but not limited to, your name, address, email address, telephone number, gender, banking details, employment, health or other information.
4.
RESPONSIBILITIES OF WFH
4.1
The WFH will fulfill all requirements to protect, collect, use, disclose and retain personal information under the Acts and all other applicable laws and regulations. We attach great importance to the proper management of your data and take full responsibility for it.
4.2
The WFH will also ensure that it has reasonable security measures in place to protect and respect the confidentiality of any personal information in its custody and control.
5.
HOW DO WE COLLECT YOUR CONSENT?
5.1
The WFH considers you to have validly consented to the collection, use or disclosure of your personal information if (i) you give your express written or oral consent; (ii) you voluntarily provide personal information for an obvious purpose; or (iii) if you do not object to the collection, use or disclosure of personal information by the WFH within a reasonable time after the WFH has given you clear notice, including through this Policy, of its intention to do so and the intended purposes.
5.2
In some cases, the WFH may collect personal information about an individual without their consent in accordance with the Acts or any other law or regulation that permits doing so.
6.
WHY WE COLLECT PERSONAL INFORMATION
6.1
We strongly believe in both minimizing the information we collect and limiting its use and purpose. WFH uses your personal information only for the purposes and for the duration required for which it was collected, or for any use that may be required or permitted by legal compliance, government request, court order or other lawful purpose.
6.2
We collect personal information for a variety of reasons. In general, WFH collects only the personal information necessary to fulfill its mission. We may also collect information for administrative purposes — to better understand the visitors who come to our websites and/or Platforms and the content of our websites and/or Platforms that is of interest to them. The purposes for which we collect personal information include, but are not limited to:
Improve the content, offering, appearance and usefulness of our Websites and/or Platforms;
Send, subject to your right to withdraw your consent as set out in this Policy, periodic emails;
Personalize your experience by responding to your needs;
Provide you with information or resources you have requested;
Process a donation and issue tax receipts;
Meet legal and regulatory requirements;
Prevent potentially prohibited or illegal activities for risk management, fraud detection and security purposes.
6.3
Wherever possible, rather than using personal information, we will anonymize and/or aggregate personal information so that it no longer identifies an individual and use it for the purposes stated above or for any purpose permitted by law.
6.4
If we ever wish to use or disclose your personal information for purposes other than those specifically described in this Policy, we will obtain your consent.
7.
WHAT PERSONAL INFORMATION DO WE COLLECT?
7.1
WFH only collects personal information that is directly related to one of our programs or activities. We take steps to ensure that the personal information we collect about you is adequate, relevant, not excessive and used for limited purposes. We collect only the information we need.
7.2
The WFH collects information on its Websites and/or Platforms in two ways:
7.2.1
Information you provide directly to us: In many cases, we collect personal information directly from you when you provide your information by subscribing to our Newsletter, when you fill out other forms on our Websites and/or Platforms, when you make an inquiry or when you contact us in person or through the WFH Websites and/or Platforms. The provision of this information is strictly voluntary. We strongly encourage you not to provide any information beyond what is necessary.
7.2.2
Information collected automatically: You should be aware that when you access or browse our Websites and/or Platforms, an exchange of information, subject to your prior consent, takes place automatically between your device and WFH's hosting environment. This exchange is required only because of the technological demands inherent in Internet browsing and is used for statistical purposes to improve your experience — the information exchanged does not identify you personally. The information exchanged is as follow:
The domain name of your internet service provider;
Your computer's truncated IP address (your IP address is changed, making it impossible to link to you);
The type of browser (Chrome, Edge, Firefox, Safari, etc.) and operating system (Windows, Mac OS, etc.) used;
The date and time of your visit;
The pages you consult and the duration of these consultations;
The address of the referring site, if you access WFH Websites and Platforms from another site.
WFH retains only the information necessary to count the number of visitors, the most frequently visited pages, the technology used by visitors, the referring sites and the country of origin of visitors. This information is not used in any way to compile, communicate or exchange lists of users/visitors.
7.3
By using the WFH Websites and/or Platforms, you agree to the terms and conditions set forth in this Privacy Policy.
8.
USE OF COOKIES
8.1
The main types of data collected on WFH Websites and/or Platforms are cookies and personalization settings. Cookies are small text files that are downloaded when you visit certain pages of a site and stored in the memory of the device you are using. Cookies are completely harmless and cannot contain any viruses. They enable certain information (browser type, language, country, identifier, etc.) to be recorded and retrieved by the server on subsequent visits. Under no circumstances do cookies allow visitors to be identified. The data remains completely anonymous and is used only to facilitate browsing and improve the WFH’s Websites and/or Platforms based on the needs of its visitors.
8.2
If you do not wish cookies to be used, your browser options can be configured to refuse and/or delete cookies. Please note that disabling or deleting cookies may deprive you of certain functions offered on our Websites and/or Platforms. In addition, this procedure must be repeated for each browser and computer used.
8.3
Google Analytics. We also gather information automatically about visits to our Websites and/or Platforms to help us maintain and improve its design, and to evaluate traffic statistics, such as the times of day and days of week at which we see peak traffic, and to assess the relative popularity of different areas of the Websites and/or Platforms. We use Google Analytics to gather this data and analyze it. Google Analytics collects information about the date and time in which our Websites and/or Platforms were accessed, and may also track a visitor’s movement within the site, but does not collect personal information about the visitor. You can install the Google Analytics Opt-out Browser Add-on to prevent information about your visits to our Websites and/or Platforms being sent to Google Analytics. Our web statistics software (Google Analytics) collects information about the date and time in which our Websites and/or Platforms were accessed, and we may also track a user’s movement within the Websites and/or Platforms. We use this data to improve our Websites and/or Platforms performance.
8.4
Meta Pixel. WFH also uses web beacons (“Pixels”) to analyze visitor activity to our Websites and/or Platforms. We use Meta Pixel to collect information about your interactions with our Websites and/or Platforms, such as pages visited, actions taken, buttons clicked and any pages visited as a result of the button clicks. Web beacons do not contain any personal information but may contain a unique identifier necessary for retargeting and targeted advertising. Meta Pixel allows us to measure the effectiveness of our advertising by understanding the actions you take on our Websites and/or Platforms. We use this data solely for analytical purposes to improve our services and deliver more relevant content.
9.
RESPONSES TO JOB OFFERS
9.1
If you have applied for a job with WFH, we will use your personal information for recruitment and other human resources purposes. We keep the documents sent (CV, cover letter, etc.) by the candidates for a maximum of three (3) years. Documents are then securely destroyed.
10.
PROTECTION OF THE PRIVACY OF MINORS
10.1
WFH does not knowingly collect personal information from children under the age of 14 without the consent of the child's parent or legal guardian. If we learn that we have collected or received personal information from a child for whom parental confirmation was required, we will delete that information. If you believe that we may have received information from or about a child for whom we should have obtained parental consent, please contact us.
11.
DO WE DISCLOSE YOUR PERSONAL INFORMATION TO THIRD PARTIES?
11.1
Rest assured that WFH will never sell, trade, rent, share or transfer your personal information to third parties (organizations or individuals) for commercial purposes without your consent, except in the exceptional cases specifically provided for in this Policy.
11.2
As part of the services offered by our external suppliers. WFH may transfer personal information that we collect or that you provide as described in this Policy to service providers and other third parties we use to support our organization. Such third parties are contractually obligated to keep personal information confidential, use it only for the purposes for which we disclose it and process personal information in accordance with the standards set out in this Policy and in compliance with the Acts.
11.3
In the context of a legal obligation. WFH may disclose your personal information to comply with any court order, law or legal process, including to respond to any government or regulatory request, in accordance with applicable law, to combat fraud or harms to WFH or our members, or if we believe that disclosure is necessary or appropriate to protect the rights, property or safety of WFH or others.
12.
SHARING PERSONAL INFORMATION OUTSIDE QUÉBEC
12.1
Your personal information is processed and stored in Québec. In order to carry out our mission, we may in some cases store, process and transfer your information around the world, including outside Québec or to jurisdictions outside your country of residence — if you are located in the Economic European Area or Switzerland, please review Appendix A "Additional terms" which apply to you in addition to the main terms of this Policy. Data may also be stored locally on the devices you use to access WFH Websites and/or Platforms.
12.2
In such cases, the transfer will only take place if we find that the information would be adequately protected, in particular considering the sensitivity of the information, the purpose for which it is used, the protection the information would be afforded, and the legal framework applicable in the state or province where the information would be transferred. Any transfer will also be subject to appropriate contractual agreements to ensure adequate protection.
13.
HOW DO WE PROTECT YOUR PERSONAL INFORMATION?
13.1
The security of your personal information is very important to us. The personal information we collect is stored in a secure environment using industry-recognized technologies. We will protect personal information against loss or theft, unauthorized access, use or disclosure, copying, modification or destruction.
13.2
When you visit our Websites and/or Platforms and are asked for personal information, this information is used exclusively by WFH. In order to protect your personal information, we have implemented customary security measures that are appropriate to the sensitivity of the information collected, including the following physical, organizational, contractual and technological measures:
Information stored in a protected database;
Encrypted communications using the TLS protocol;
Access to your personal information is restricted to those employees who need it to perform their duties (authorized and/or concerned persons) — these employees will treat the information as strictly confidential and will not give access to this information to any unauthorized person;
Report any violation of this Policy or the Acts to the WFH Privacy Officer;
Network monitoring software;
Anti-virus and anti-malware;
End-user device encryptions;
Passwords and multi-factor authentication;
Firewall;
Secure Web site donation page; content encrypted or encoded to make information unreadable;
Paper files kept in locked filing cabinets wherever possible;
Access codes to WFH premises;
Security personnel.
13.3
Individuals working for WFH or acting on our behalf must make reasonable efforts to minimize the risk of unintentional disclosure of personal information. In addition, our policies, procedures and codes of conduct are clearly communicated to our employees, contractors, volunteers, consultants and subcontractors and WFH will ensure that they are adhered to and respected. All individuals who fail to comply with the principles and procedures of this Policy will be subject to corrective measures, including termination of their employment relationship, tenure or contract.
13.4
Despite these precautions, no method of transmission or storage is 100% secure or error-free. As a result, we cannot guarantee absolute security. If you have reason to believe that your interaction with us is no longer secure, please contact us immediately.
13.5
If we become aware of a security breach involving your personal information, we will notify you and the appropriate authorities as soon as possible, in accordance with the Acts.
14.
RETENTION AND DESTRUCTION OF PERSONAL INFORMATION
14.1
Except as permitted or required by the Acts or any applicable law or regulation, WFH will retain your personal information only for as long as necessary to fulfill the purposes for which we collected it, including for the purposes of satisfying legal, accounting or reporting requirements to the appropriate government and regulatory bodies.
14.2
Personal information that is no longer required for the purposes for which it was collected will be destroyed, erased or made anonymous in accordance with applicable laws.
14.3
Under some circumstances, we may anonymize your personal information so that it can no longer be associated with you. We reserve the right to use de-identified and anonymized data for any legitimate purpose without further notice to you or your consent.
14.4
If the WFH uses personal information to make a decision that directly affects an individual, we will retain that information for as long as necessary to fulfill the purposes for which the information was collected. Once the information has been used, individuals may access their personal information as set out in the Acts.
15.
ACCESSING, CORRECTING, DE-INDEXING AND PORTABILITY OF YOUR PERSONAL INFORMATION
15.1
It is important that the personal information we hold about you is accurate and current. Please keep us informed if your personal information changes. You can contact us via the WFH Online Contact Form or email us at [email protected].
15.2
Upon request, an individual is entitled to be informed of the existence, use and disclosure of their personal information and to obtain access to that information, or to obtain a copy of their personal information in electronic or non-electronic format subject to appropriate notice. An individual has the right to challenge the accuracy and completeness of their personal information, have it amended, or withdraw consent to the use of their information. In addition, WFH complies with all laws regarding access to and correction of your personal information.
15.3
An individual has also the right to receive computerized personal information collected from them in a structured, machine-readable, and commonly used format. In certain circumstances, the individual may also ask WFH to transfer their computerized personal information directly to third parties. An individual has the right to request that the dissemination of their personal information cease, or to request that any hyperlinks associated with their name and that provide access to personal information be de-indexed or re-indexed.
15.4
No request for access, rectification, de-indexation or data portability may be considered unless it is made in writing and addressed to the WFH Privacy Officer. You must provide enough detail to enable the WFH to process the request. The Privacy Officer will respond within 30 days of the receipt of a request, unless it extends the time as authorized under the Acts.
16.
WITHDRAWING YOUR CONSENT
16.1
If you have given your consent to the collection, use and transfer of your personal information, you may have the legal right to withdraw your consent under certain circumstances. To withdraw your consent, if applicable, contact us at [email protected].
16.2
Please note that if you withdraw your consent, we may not be able to provide you with certain services. We will explain the impact of withdrawing your consent to help you make a decision.
17.
CHANGES TO OUR PRIVACY POLICY
17.1
WFH will review and update its policies and procedures as required to keep current with rules and regulations, new technologies and standards. Our Privacy Policy may therefore change from time to time. We will post any Policy changes on our Websites and Platforms and, if the changes are significant, we will provide a more prominent notice. You are responsible for periodically visiting our Websites and/or Platforms and this Policy to check for any changes.
17.2
Please note that both the English and French versions of our Privacy Policy have equal legal value.
18.
CONTACT DETAILS FOR THE PRIVACY OFFICER
If you have any comments, questions or requests regarding this Policy or our privacy practices, or to report any abuse by third parties, please do not hesitate to contact Antonio José Almeida, WFH Senior Director, Operations and Privacy Officer by e-mail at [email protected] or at the following postal address:
c/o Privacy Officer, World Federation of Hemophilia
1184 rue Sainte-Catherine Ouest
Suite 500
Montreal, Québec
H3B 1K1
Canada
We have procedures in place to receive and respond to complaints or inquiries about our handling of personal information, our compliance with this Policy and applicable privacy laws.
If you are not satisfied with WFH's handling of your personal information, you may file a complaint with WFH. The complaint will be investigated by the WFH Privacy Officer, who will determine whether the handling of the information complies with WFH policies and practices and any other applicable laws. The Privacy Officer will make every reasonable effort to resolve complaints. The person filing the complaint will be informed of any progress or outcome of the investigation within a maximum of 30 working days of receipt of the request and/or any additional time required to complete the investigation.
APPENDIX A
ADDITIONAL TERMS FOR USERS LOCATED IN THE ECONOMIC EUROPEAN AREA (EEA) AND SWITZERLAND
If you are located in the European Economic Area (EEA) or Switzerland, these additional terms apply to you in addition to the main terms of WFH Privacy Policy. In case of a contradiction between the Privacy Policy and these additional terms, the latter will prevail.
1
LEGAL BASIS FOR PROCESSING PERSONAL INFORMATION UNDER THE GENERAL DATA PROTECTION REGULATION (GDPR)
1.1
If you are from the European Economic Area (EEA) or Switzerland, WFH’s legal basis for collecting and using the personal information described in this Privacy Policy depends on the personal information we collect and the specific context in which we collect it. We only process your Personal information if we have a legal basis to do so, which includes:
Consent: where you have given us your consent, you have given us permission to do so, or where processing is necessary for the performance of a service you have requested; or
Legitimate interests: for example, we may process your personal information to protect you, us, or others from threats (such as security threats or fraud), to comply with laws that apply to us.
If you have any questions about the lawful bases upon which we collect and use your personal data, please contact:
Antonio José Almeida, WFH Senior Director, Operations and Privacy Officer by e-mail at [email protected] or at the following postal address: c/o Privacy Officer, World Federation of Hemophilia, 1184 rue Sainte-Catherine Ouest Suite 500, Montreal, Québec, H3B 1K1, Canada
2
TRANSFER OF YOUR PERSONAL INFORMATION OUTSIDE OF THE EEA OR SWITZERLAND
2.1
We may process information outside of the EEA or Switzerland, including Canada and the USA.
3
ADDITIONAL RIGHTS REGARDING YOUR PERSONAL INFORMATION UNDER THE GENERAL DATA PROTECTION REGULATION (GDPR)
3.1
If you are a resident of the European Economic Area (EEA) or Switzerland, you have certain data protection rights. WFH aims to take reasonable steps to allow you to correct, amend, delete or limit the use of your personal information.
3.2
If you wish to be informed about what personal information we hold about you and if you want it to be removed from our systems, please contact us.
3.3
In addition to the rights mentioned in the section 15 ("Accessing, correcting, de-indexing and portability of your personal information") and in section 16 ("Withdrawing your consent"), in certain circumstances, you also have the following data protection right:
The right to delete the information we have on you. Whenever made possible, you can request deletion of your personal information, in which case we will carry out this request unless certain exceptional reasons arise permitting us to keep certain information about you;
The right to object. You have the right to object to our processing of your personal information in certain circumstances, such as those described in the “Legitimate interests” section 1.1 b) above. We may however continue to process your personal Information unless your interests, rights and freedoms override our legitimate interests; and
The right of restriction. You have the right to request that we restrict or limit the ways in which we process your personal information for instance where you believe your data is inaccurate.
Please note that we may ask you to verify your identity before responding to such requests.
1.PURPOSE
1.1
This WFH Digital Platforms Privacy Policy (hereinafter "Policy" or "Privacy Policy") explains not only how we collect, use, disclose and store any information related to your personal data when you visit any Website (or "Websites") or mobile applications ("Applications" or "Platforms") operated by WFH, but also how you can access, update or take control of your personal information.
1.2
This Policy replaces and updates the WFH Website Privacy Policy (IT 003).
2.SCOPE
2.1
This Policy generally applies to:
any personal information of a factual or subjective nature about an identifiable individual collected through the Websites and/or Platforms on which this Policy is posted, or through any other interactions you may have with us;
WFH staff members (regular employees, temporary employees and contractual resources) and senior management who handle personal information held by WFH;
visitors to our Websites and/or Platforms, our volunteers and Board members, and any person or company acting for or on behalf of WFH.
2.2
External links. This Policy does not apply to links to third-party websites, plug-ins, services, social networks or applications, including those offered via hyperlinks displayed on our Websites and/or Platforms. If you follow a link to a third-party website or use a third-party plug-in, please note that these third parties have their own privacy policies and we do not accept any responsibility or liability for those policies. We do not control these third-party websites and encourage you to read the privacy policy of each site you visit before providing them with any personal information.
3.DEFINITION OF "PERSONAL INFORMATION"
3.1
When used in this Privacy Policy, “personal information” means any information about an individual that can be used to identify an individual, including, but not limited to, your name, address, email address, telephone number, gender, banking details, employment, health or other information.
4.RESPONSIBILITIES OF WFH
4.1
The WFH will fulfill all requirements to protect, collect, use, disclose and retain personal information under the Acts and all other applicable laws and regulations. We attach great importance to the proper management of your data and take full responsibility for it.
4.2
The WFH will also ensure that it has reasonable security measures in place to protect and respect the confidentiality of any personal information in its custody and control.
5.HOW DO WE COLLECT YOUR CONSENT?
5.1
The WFH considers you to have validly consented to the collection, use or disclosure of your personal information if (i) you give your express written or oral consent; (ii) you voluntarily provide personal information for an obvious purpose; or (iii) if you do not object to the collection, use or disclosure of personal information by the WFH within a reasonable time after the WFH has given you clear notice, including through this Policy, of its intention to do so and the intended purposes.
5.2
In some cases, the WFH may collect personal information about an individual without their consent in accordance with the Acts or any other law or regulation that permits doing so.
6.WHY WE COLLECT PERSONAL INFORMATION
6.1
We strongly believe in both minimizing the information we collect and limiting its use and purpose. WFH uses your personal information only for the purposes and for the duration required for which it was collected, or for any use that may be required or permitted by legal compliance, government request, court order or other lawful purpose.
6.2
We collect personal information for a variety of reasons. In general, WFH collects only the personal information necessary to fulfill its mission. We may also collect information for administrative purposes — to better understand the visitors who come to our websites and/or Platforms and the content of our websites and/or Platforms that is of interest to them. The purposes for which we collect personal information include, but are not limited to:
Improve the content, offering, appearance and usefulness of our Websites and/or Platforms;
Send, subject to your right to withdraw your consent as set out in this Policy, periodic emails;
Personalize your experience by responding to your needs;
Provide you with information or resources you have requested;
Process a donation and issue tax receipts;
Meet legal and regulatory requirements;
Prevent potentially prohibited or illegal activities for risk management, fraud detection and security purposes.
6.3
Wherever possible, rather than using personal information, we will anonymize and/or aggregate personal information so that it no longer identifies an individual and use it for the purposes stated above or for any purpose permitted by law.
6.4
If we ever wish to use or disclose your personal information for purposes other than those specifically described in this Policy, we will obtain your consent.
7.WHAT PERSONAL INFORMATION DO WE COLLECT?
7.1
WFH only collects personal information that is directly related to one of our programs or activities. We take steps to ensure that the personal information we collect about you is adequate, relevant, not excessive and used for limited purposes. We collect only the information we need.
7.2
The WFH collects information on its Websites and/or Platforms in two ways:
7.2.1
Information you provide directly to us: In many cases, we collect personal information directly from you when you provide your information by subscribing to our Newsletter, when you fill out other forms on our Websites and/or Platforms, when you make an inquiry or when you contact us in person or through the WFH Websites and/or Platforms. The provision of this information is strictly voluntary. We strongly encourage you not to provide any information beyond what is necessary.
7.2.2
Information collected automatically: You should be aware that when you access or browse our Websites and/or Platforms, an exchange of information, subject to your prior consent, takes place automatically between your device and WFH's hosting environment. This exchange is required only because of the technological demands inherent in Internet browsing and is used for statistical purposes to improve your experience — the information exchanged does not identify you personally. The information exchanged is as follow:
The domain name of your internet service provider;
Your computer's truncated IP address (your IP address is changed, making it impossible to link to you);
The type of browser (Chrome, Edge, Firefox, Safari, etc.) and operating system (Windows, Mac OS, etc.) used;
The date and time of your visit;
The pages you consult and the duration of these consultations;
The address of the referring site, if you access WFH Websites and Platforms from another site.
WFH retains only the information necessary to count the number of visitors, the most frequently visited pages, the technology used by visitors, the referring sites and the country of origin of visitors. This information is not used in any way to compile, communicate or exchange lists of users/visitors.
7.3
By using the WFH Websites and/or Platforms, you agree to the terms and conditions set forth in this Privacy Policy.
8.USE OF COOKIES
8.1
The main types of data collected on WFH Websites and/or Platforms are cookies and personalization settings. Cookies are small text files that are downloaded when you visit certain pages of a site and stored in the memory of the device you are using. Cookies are completely harmless and cannot contain any viruses. They enable certain information (browser type, language, country, identifier, etc.) to be recorded and retrieved by the server on subsequent visits. Under no circumstances do cookies allow visitors to be identified. The data remains completely anonymous and is used only to facilitate browsing and improve the WFH’s Websites and/or Platforms based on the needs of its visitors.
8.2
If you do not wish cookies to be used, your browser options can be configured to refuse and/or delete cookies. Please note that disabling or deleting cookies may deprive you of certain functions offered on our Websites and/or Platforms. In addition, this procedure must be repeated for each browser and computer used.
8.3
Google Analytics. We also gather information automatically about visits to our Websites and/or Platforms to help us maintain and improve its design, and to evaluate traffic statistics, such as the times of day and days of week at which we see peak traffic, and to assess the relative popularity of different areas of the Websites and/or Platforms. We use Google Analytics to gather this data and analyze it. Google Analytics collects information about the date and time in which our Websites and/or Platforms were accessed, and may also track a visitor’s movement within the site, but does not collect personal information about the visitor. You can install the Google Analytics Opt-out Browser Add-on to prevent information about your visits to our Websites and/or Platforms being sent to Google Analytics. Our web statistics software (Google Analytics) collects information about the date and time in which our Websites and/or Platforms were accessed, and we may also track a user’s movement within the Websites and/or Platforms. We use this data to improve our Websites and/or Platforms performance.
8.4
Meta Pixel. WFH also uses web beacons (“Pixels”) to analyze visitor activity to our Websites and/or Platforms. We use Meta Pixel to collect information about your interactions with our Websites and/or Platforms, such as pages visited, actions taken, buttons clicked and any pages visited as a result of the button clicks. Web beacons do not contain any personal information but may contain a unique identifier necessary for retargeting and targeted advertising. Meta Pixel allows us to measure the effectiveness of our advertising by understanding the actions you take on our Websites and/or Platforms. We use this data solely for analytical purposes to improve our services and deliver more relevant content.
9.RESPONSE TO JOB OFFERS
9.1
If you have applied for a job with WFH, we will use your personal information for recruitment and other human resources purposes. We keep the documents sent (CV, cover letter, etc.) by the candidates for a maximum of three (3) years. Documents are then securely destroyed.
10.PROTECTION OF THE PRIVACY OF MINORS
10.1
WFH does not knowingly collect personal information from children under the age of 14 without the consent of the child's parent or legal guardian. If we learn that we have collected or received personal information from a child for whom parental confirmation was required, we will delete that information. If you believe that we may have received information from or about a child for whom we should have obtained parental consent, please contact us.
11.DO WE DISCLOSE YOUR PERSONAL INFORMATION TO THIRD PARTIES?
11.1
Rest assured that WFH will never sell, trade, rent, share or transfer your personal information to third parties (organizations or individuals) for commercial purposes without your consent, except in the exceptional cases specifically provided for in this Policy.
11.2
As part of the services offered by our external suppliers. WFH may transfer personal information that we collect or that you provide as described in this Policy to service providers and other third parties we use to support our organization. Such third parties are contractually obligated to keep personal information confidential, use it only for the purposes for which we disclose it and process personal information in accordance with the standards set out in this Policy and in compliance with the Acts.
11.3
In the context of a legal obligation. WFH may disclose your personal information to comply with any court order, law or legal process, including to respond to any government or regulatory request, in accordance with applicable law, to combat fraud or harms to WFH or our members, or if we believe that disclosure is necessary or appropriate to protect the rights, property or safety of WFH or others.
12.SHARING PERSONAL INFORMATION OUTSIDE QUÉBEC
12.1
Your personal information is processed and stored in Québec. In order to carry out our mission, we may in some cases store, process and transfer your information around the world, including outside Québec or to jurisdictions outside your country of residence — if you are located in the Economic European Area or Switzerland, please review Appendix A "Additional terms" which apply to you in addition to the main terms of this Policy. Data may also be stored locally on the devices you use to access WFH Websites and/or Platforms.
12.2
In such cases, the transfer will only take place if we find that the information would be adequately protected, in particular considering the sensitivity of the information, the purpose for which it is used, the protection the information would be afforded, and the legal framework applicable in the state or province where the information would be transferred. Any transfer will also be subject to appropriate contractual agreements to ensure adequate protection.
13.HOW DO WE PROTECT YOUR PERSONAL INFORMATION?
13.1
The security of your personal information is very important to us. The personal information we collect is stored in a secure environment using industry-recognized technologies. We will protect personal information against loss or theft, unauthorized access, use or disclosure, copying, modification or destruction.
13.2
When you visit our Websites and/or Platforms and are asked for personal information, this information is used exclusively by WFH. In order to protect your personal information, we have implemented customary security measures that are appropriate to the sensitivity of the information collected, including the following physical, organizational, contractual and technological measures:
Information stored in a protected database;
Encrypted communications using the TLS protocol;
Access to your personal information is restricted to those employees who need it to perform their duties (authorized and/or concerned persons) — these employees will treat the information as strictly confidential and will not give access to this information to any unauthorized person;
Report any violation of this Policy or the Acts to the WFH Privacy Officer;
Network monitoring software;
Anti-virus and anti-malware;
End-user device encryptions;
Passwords and multi-factor authentication;
Firewall;
Secure Web site donation page; content encrypted or encoded to make information unreadable;
Paper files kept in locked filing cabinets wherever possible;
Access codes to WFH premises;
Security personnel.
13.3
Individuals working for WFH or acting on our behalf must make reasonable efforts to minimize the risk of unintentional disclosure of personal information. In addition, our policies, procedures and codes of conduct are clearly communicated to our employees, contractors, volunteers, consultants and subcontractors and WFH will ensure that they are adhered to and respected. All individuals who fail to comply with the principles and procedures of this Policy will be subject to corrective measures, including termination of their employment relationship, tenure or contract.
13.4
Despite these precautions, no method of transmission or storage is 100% secure or error-free. As a result, we cannot guarantee absolute security. If you have reason to believe that your interaction with us is no longer secure, please contact us immediately.
13.5
If we become aware of a security breach involving your personal information, we will notify you and the appropriate authorities as soon as possible, in accordance with the Acts.
14.RETENTION AND DESTRUCTION OF PERSONAL INFORMATION
14.1
Except as permitted or required by the Acts or any applicable law or regulation, WFH will retain your personal information only for as long as necessary to fulfill the purposes for which we collected it, including for the purposes of satisfying legal, accounting or reporting requirements to the appropriate government and regulatory bodies.
14.2
Personal information that is no longer required for the purposes for which it was collected will be destroyed, erased or made anonymous in accordance with applicable laws.
14.3
Under some circumstances, we may anonymize your personal information so that it can no longer be associated with you. We reserve the right to use de-identified and anonymized data for any legitimate purpose without further notice to you or your consent.
14.4
If the WFH uses personal information to make a decision that directly affects an individual, we will retain that information for as long as necessary to fulfill the purposes for which the information was collected. Once the information has been used, individuals may access their personal information as set out in the Acts.
15.ACCESSING, CORRECTING, DE-INDEXING AND PORTABILITY OF YOUR PERSONAL INFORMATION
15.1
It is important that the personal information we hold about you is accurate and current. Please keep us informed if your personal information changes. You can contact us via the WFH Online Contact Form or email us at [email protected].
15.2
Upon request, an individual is entitled to be informed of the existence, use and disclosure of their personal information and to obtain access to that information, or to obtain a copy of their personal information in electronic or non-electronic format subject to appropriate notice. An individual has the right to challenge the accuracy and completeness of their personal information, have it amended, or withdraw consent to the use of their information. In addition, WFH complies with all laws regarding access to and correction of your personal information.
15.3
An individual has also the right to receive computerized personal information collected from them in a structured, machine-readable, and commonly used format. In certain circumstances, the individual may also ask WFH to transfer their computerized personal information directly to third parties. An individual has the right to request that the dissemination of their personal information cease, or to request that any hyperlinks associated with their name and that provide access to personal information be de-indexed or re-indexed.
15.4
No request for access, rectification, de-indexation or data portability may be considered unless it is made in writing and addressed to the WFH Privacy Officer. You must provide enough detail to enable the WFH to process the request. The Privacy Officer will respond within 30 days of the receipt of a request, unless it extends the time as authorized under the Acts.
16.WITHDRAWING YOUR CONSENT
16.1
If you have given your consent to the collection, use and transfer of your personal information, you may have the legal right to withdraw your consent under certain circumstances. To withdraw your consent, if applicable, contact us at [email protected].
16.2
Please note that if you withdraw your consent, we may not be able to provide you with certain services. We will explain the impact of withdrawing your consent to help you make a decision.
17.CHANGES TO OUR PRIVACY POLICY
17.1
WFH will review and update its policies and procedures as required to keep current with rules and regulations, new technologies and standards. Our Privacy Policy may therefore change from time to time. We will post any Policy changes on our Websites and Platforms and, if the changes are significant, we will provide a more prominent notice. You are responsible for periodically visiting our Websites and/or Platforms and this Policy to check for any changes.
17.2
Please note that both the English and French versions of our Privacy Policy have equal legal value.
18.CONTACT DETAILS FOR THE PRIVACY OFFICER
If you have any comments, questions or requests regarding this Policy or our privacy practices, or to report any abuse by third parties, please do not hesitate to contact Antonio José Almeida, WFH Senior Director, Operations and Privacy Officer by e-mail at [email protected] or at the following postal address:
c/o Privacy Officer, World Federation of Hemophilia
1184 rue Sainte-Catherine Ouest
Suite 500
Montreal, Québec
H3B 1K1
Canada
We have procedures in place to receive and respond to complaints or inquiries about our handling of personal information, our compliance with this Policy and applicable privacy laws.
If you are not satisfied with WFH's handling of your personal information, you may file a complaint with WFH. The complaint will be investigated by the WFH Privacy Officer, who will determine whether the handling of the information complies with WFH policies and practices and any other applicable laws. The Privacy Officer will make every reasonable effort to resolve complaints. The person filing the complaint will be informed of any progress or outcome of the investigation within a maximum of 30 working days of receipt of the request and/or any additional time required to complete the investigation.
APPENDIX A
APPENDIX A
ADDITIONAL TERMS FOR USERS LOCATED IN THE ECONOMIC EUROPEAN AREA (EEA) AND SWITZERLAND
If you are located in the European Economic Area (EEA) or Switzerland, these additional terms apply to you in addition to the main terms of WFH Privacy Policy. In case of a contradiction between the Privacy Policy and these additional terms, the latter will prevail.
1
LEGAL BASIS FOR PROCESSING PERSONAL INFORMATION UNDER THE GENERAL DATA PROTECTION REGULATION (GDPR)
1.1
If you are from the European Economic Area (EEA) or Switzerland, WFH’s legal basis for collecting and using the personal information described in this Privacy Policy depends on the personal information we collect and the specific context in which we collect it. We only process your Personal information if we have a legal basis to do so, which includes:
Consent: where you have given us your consent, you have given us permission to do so, or where processing is necessary for the performance of a service you have requested; or
Legitimate interests: for example, we may process your personal information to protect you, us, or others from threats (such as security threats or fraud), to comply with laws that apply to us.
If you have any questions about the lawful bases upon which we collect and use your personal data, please contact:
Antonio José Almeida,
WFH Senior Director, Operations and Privacy Officer by e-mail at [email protected] or at the following postal address: c/o Privacy Officer, World Federation of Hemophilia, 1184 rue Sainte-Catherine Ouest Suite 500, Montreal, Québec, H3B 1K1, Canada
2
TRANSFER OF YOUR PERSONAL INFORMATION OUTSIDE OF THE EEA OR SWITZERLAND
2.1
We may process information outside of the EEA or Switzerland, including Canada and the USA.
3
ADDITIONAL RIGHTS REGARDING YOUR PERSONAL INFORMATION UNDER THE GENERAL DATA PROTECTION REGULATION (GDPR)
3.1
If you are a resident of the European Economic Area (EEA) or Switzerland, you have certain data protection rights. WFH aims to take reasonable steps to allow you to correct, amend, delete or limit the use of your personal information.
3.2
If you wish to be informed about what personal information we hold about you and if you want it to be removed from our systems, please contact us.
3.3
In addition to the rights mentioned in the section 15 ("Accessing, correcting, de-indexing and portability of your personal information") and in section 16 ("Withdrawing your consent"), in certain circumstances, you also have the following data protection right:
The right to delete the information we have on you. Whenever made possible, you can request deletion of your personal information, in which case we will carry out this request unless certain exceptional reasons arise permitting us to keep certain information about you;
The right to object. You have the right to object to our processing of your personal information in certain circumstances, such as those described in the “Legitimate interests” section 1.1 b) above. We may however continue to process your personal Information unless your interests, rights and freedoms override our legitimate interests; and
The right of restriction. You have the right to request that we restrict or limit the ways in which we process your personal information for instance where you believe your data is inaccurate.
Please note that we may ask you to verify your identity before responding to such requests.
Condiciones de uso de las plataformas digitales de la FMH
The use of all websites and Platforms belonging to the World Federation of Hemophilia (WFH) is subject to the following terms and conditions:
By using these websites and/or Platforms, you agree to its terms and conditions, effective as of the date you first use these websites and/or Platforms.
The World Federation of Hemophilia reserves the right to change these terms and conditions at any time by posting a modification notice online. Continued use of these websites and/or Platforms following the posting of changes constitutes your acceptance of these terms, as modified.
You agree to use these websites and/or Platforms only for lawful purposes and in a manner that does not infringe the rights of third parties or restrict or impede their enjoyment of use of this site.
These websites and/or Platforms and the information contained therein, names, images, photographs, and logos concerning or making reference to the World Federation of Hemophilia are provided “as is” without any additional representation or condition and without any implicit or explicit guarantee of any sort. Under no circumstance will the World Federation of Hemophilia be responsible for any damages, including, but not limited to, indirect damages, or any other damages caused by the use of or related to the loss of use of the websites and/or Platforms, whether by contract or negligence.
The World Federation of Hemophilia does not guarantee the site’s operations will not be interrupted and/or are exempt from error, or shortcomings will be corrected.
The World Federation of Hemophilia does not guarantee that the websites and/or Platforms or server will be free of viruses or bugs, or even its full functionality or the precision and exactness of its content.
Copyright restrictions:
All information, photographs, graphics, and other material on these websites and/or Platforms are protected by copyright. While users of these websites and/or Platforms may use the content for personal, non-commercial use, none of the content of these websites and/or Platforms can be modified, translated, transferred or sold, copied, reproduced, published, or distributed, in whole or in part, without the prior written consent of the WFH.
Notwithstanding the above, certain documents and photos have been published on these websites and/or Platforms with the consent of the said copyright owners (who are not the World Federation of Hemophilia). All rights to these documents and/or photos are reserved and may not be reproduced without the consent of the copyright owners.
The WFH encourages the dissemination of its information and welcomes proposals on the reprinting, redistribution, and translation of its materials. If you would like to publish information that you find on our websites and/or Platforms, please send your request to [email protected].
The logo of the World Federation of Hemophilia and its explicitly associated graphic image elements may not be reproduced for commercial or promotional purposes without formal authorization from World Federation of Hemophilia.
If you have any questions about the practices of our websites and/or Platforms or suggestions on how to make these websites and/or Platforms more accessible, please contact us at [email protected].
The World Federation of Hemophilia is not responsible for the content of external websites to which its site may link. Throughout our websites and/or Platforms, we provide links to other servers which may contain information of interest to our readers. We assume no responsibility for, and exercise no control over, the organizations, views or accuracy of information contained on other servers. When linking to the WFH, we request that you ensure that there are no associated connections for commercial purposes. If you have a link you’d like us to consider adding to our website, please send an email to [email protected] with the subject “Link request”.
Any communication or material that is publicly transmitted or posted on these other servers, including any data, questions, suggestions, comments or other information, will be treated as non-confidential and non-proprietary information.
The World Federation of Hemophilia respects the privacy of its members and visitors to these websites and/or Platforms. In this regard, please refer to our Digital Platforms Privacy Policy.
In the event of any conflict between the terms and conditions of use herein and any specific guidelines or terms of use appearing on these websites and/or Platforms relating to specific material, the latter shall prevail. If there is a conflict between the conditions and/or regulations of this site and those applying to a specific document that may be posted, the latter takes precedent.
These terms and conditions of use shall be governed by and construed in accordance with the laws of Canada and Quebec. Any dispute shall be subject to the exclusive jurisdiction of the courts of Canada and Quebec. If the terms and conditions of use are not accepted in their entirety, use of these websites and/or Platforms must cease immediately.
El Congreso Mundial 2026 de la FMH abarcará más de 80 horas de sesiones de educación continua en segmentos médicos y para personas con trastornos de la coagulación (PCTC), así como seis segmentos de desarrollo profesional en los campos de enfermería, odontología, ciencias de laboratorio, atención psicosocial, cuidados musculoesqueléticos (MSK) y mujeres y niñas con trastornos de la coagulación (MNTC).
Los participantes disfrutarán de un programa de primer nivel que abordará los avances médicos y multidisciplinarios más recientes. Contará con ponentes de renombre mundial en sesiones plenarias, presentaciones, sesiones interactivas, talleres, mesas redondas, e innovadores simposios de la industria. Y, por supuesto, un extenso calendario social ayudará a los participantes a aprovechar al máximo su estancia en Kuala Lumpur.
Ceremonia de inauguración & Recepción de bienvenida
Abril 19|18:30 – 21:30
La ceremonia de inauguración dará oficialmente el pistoletazo de salida al Congreso Mundial 2026 de la FMH, reuniendo a todos los asistentes para celebrar el inicio del congreso. La velada continuará con la recepción de bienvenida, que ofrecerá a los participantes la oportunidad de relacionarse, establecer contactos e interactuar con colegas de todo el mundo.
Precio: 20 USD para profesionales sanitarios, 55 USD para invitados; gratuito para el resto de delegados.
Sesión de pósteres y networking
Abril 20|18:00
Acompáñenos el 20 de abril, fecha en la que se realizará el evento para establecer contactos durante la presentación de posters, el cual ofrecerá a presentadores y asistentes la oportunidad de conocerse, explorar nuevas investigaciones e intercambiar perspectivas sobre los acontecimientos más recientes en el campo de los trastornos de la coagulación.
Costo: Incluido para todos los delegados
Interpretación simultánea
Algunas sesiones seleccionadas del Congreso Mundial de la FMH 2026 ofrecerán interpretación asistida por IA en más de 50 idiomas, lo que ayudará a romper las barreras lingüísticas y hará que las conversaciones globales sean más accesibles para todos.
El Congreso Mundial 2026 de la FMH contará con ocho segmentos programáticos únicos a fin de ayudarle a preparar un cronograma con las sesiones y talleres que sean de más utilidad para usted.
Segmentos principales
Segmento médico
Con más de 50 expertos de más de 20 países, el Segmento médico le permitirá explorar los avances más innovadores en diagnóstico, tratamiento y manejo a largo plazo de los trastornos de la coagulación. Las sesiones abarcarán desde análisis genéticos de gran escala e innovaciones en edición génica, hasta implementación de la terapia génica en el mundo real. Los expertos abordarán trastornos incipientes y poco comunes, terapias sin factor y miméticas en evolución, y desafíos médicos prácticos, desde las hemorragias neonatales hasta el envejecimiento de los pacientes.
Segmento para personas con trastornos de la coagulación (PCTC)
El Segmento para PCTC destacará la experiencia vivida y las cambiantes necesidades de las personas con trastornos de la coagulación; brindará además una plataforma dinámica para el intercambio de experiencias, el aprendizaje y la participación en innovaciones incipientes relacionadas con la atención. Estas sesiones, que abarcarán temas como acceso al tratamiento, salud digital, salud mental, planificación familiar, envejecimiento y bienestar, enfatizarán los conocimientos prácticos, las perspectivas compartidas, y la innovación centrada en el paciente a fin de mejorar la calidad de vida y empoderar a la comunidad mundial de trastornos de la coagulación.
Segmentos de desarrollo profesional
Segmento de odontología
El Segmento de odontología se centrará en las singulares necesidades de atención dental de las PCTC a lo largo de su vida. Explorará la salud oral de mujeres y niñas, la transición de la atención pediátrica a la atención adulta, el envejecimiento y los trastornos poco comunes, con un taller práctico sobre cuidados preventivos, higiene oral y control de hemorragias para pacientes y cuidadores.
Segmento de ciencias de laboratorio
El Segmento de ciencias de laboratorio le guiará desde los fundamentos de los análisis hemostáticos hasta las novedades más recientes en diagnóstico avanzado. Las sesiones encabezadas por expertos explorarán enfoques de laboratorio para la hemofilia, la enfermedad de Von Willebrand (EVW) y los trastornos plaquetarios, combinando conocimientos clásicos con innovaciones de vanguardia tales como terapia génica, terapias novedosas y secuenciación de nueva generación. Este programa incluirá tres talleres de desarrollo profesional, incluso un nuevo taller que ofrecerá experiencia práctica con ensayos manuales, control de calidad y pruebas plaquetarias y de coagulación.
Segmento sobre temas musculoesqueléticos (MSK)
El Segmento sobre temas musculoesqueléticos abarcará todo el espectro de la salud y la función articular en personas con trastornos de la coagulación, desde la comprensión de la patología articular y el manejo quirúrgico hasta análisis por imágenes, rehabilitación y atención a largo plazo. Las sesiones comprenderán actualizaciones en diagnóstico, salud musculoesquelética pediátrica y femenina, y acceso a la atención a escala mundial. Tres talleres, sobre ultrasonido, terapia manual y ejercicios de fortalecimiento, ofrecerán habilidades prácticas, además de conocimientos médicos.
Segmento de enfermería
El Segmento de enfermería destacará el papel esencial del personal de enfermería en la atención y el tratamiento de PCTC. Las sesiones abordarán la atención integral, inclusive valoraciones de la salud musculoesquelética y oral, desarrollo de servicios, trastornos poco comunes de la coagulación, salud femenina, y aplicación de nuevas terapias. Participe en la jornada de desarrollo profesional para adquirir herramientas prácticas, participar en análisis de casos, y explorar estrategias a fin de mejorar la práctica de la enfermería, el liderazgo y los resultados de los pacientes en todo el mundo.
Segmento sobre temas psicosociales
El Segmento sobre temas psicosociales examinará las dimensiones psicológicas, sociales y culturales de lo que representa vivir con un trastorno de la coagulación. Las sesiones abordarán salud mental, apoyo comunitario y entre pares, identidad en las distintas etapas de la vida, bienestar de los cuidadores, e implicaciones psicosociales de nuevos tratamientos como la terapia génica. Participe en el taller sobre temas psicosociales para adquirir habilidades y herramientas prácticas, y establecer contactos a escala regional a fin de aprender más sobre cómo fortalecer la atención en todo el mundo.
Segmento sobre mujeres y niñas con trastornos de la coagulación (MNTC)
El Segmento sobre MNTC destacará a una población a menudo desatendida, centrándose en los desafíos únicos que enfrentan mujeres y niñas con trastornos de la coagulación. Las sesiones abordarán salud menstrual, diagnóstico tardío, toma de decisiones compartidas, salud ósea y atención multidisciplinaria, ofreciendo herramientas prácticas, análisis de casos, y estrategias para empoderar a las pacientes y mejorar sus resultados a lo largo de su vida.
Stronger Together: Creating More Access to Advanced Prophylactic Treatment, Globally
Join an interactive discussion exploring the impact of advanced prophylaxis for people living with haemophilia A. Discover how strong patient communities, advocacy, and collaboration can unlock better access to advanced prophylaxis worldwide. Hear real-world insights and lessons learned from Pakistan and New Zealand—and be part of the conversation shaping a more equitable future in haemophilia care.
12:45 – 13:45
BANQUET HALL | Sanofi
Rebalancing Hemostasis: Advancing Hemophilia Care
17:30 – 18:30
BANQUET HALL | Octapharma
Beyond Replacement: Redefining Factor VIII and Inhibitor Care in Haemophilia A *
Join Alok Srivastava (IN), Anna Pavlova (DE), and Robert F. Sidonio Jr. (US) to explore current challenges and evolving strategies in haemophilia A management, with a focus on the role of Factor VIII in the modern treatment landscape. Expert faculty will discuss individualised treatment decisions, genetic risk factors for inhibitor development, and modern approaches to inhibitor eradication.
* This session is for healthcare professionals only.
Together for Tomorrow: Advancing Global Hemophilia Care Through Partnership
This symposium will explore the evolving landscape of hemophilia care. Drawing on global insights and experience from the WFH Twinning Program, faculty will examine regional unmet needs and the impact of global collaboration in advancing equitable, patient-centered care worldwide.
*
The World Federation of Hemophilia does not endorse particular treatment products or manufacturers; any reference to a product name is not an endorsement by the WFH. The WFH is not a regulatory agency and cannot make recommendations relating to safety of manufacturing of specific treatment products. Some sessions may be accessible to healthcare professionals only.
PRESENTATION THEATRE
Join us in MR304-305 for these presentation theatre sessions:
DAY 1 | April 20
DAY 2 | April 21
10:55 to 11:25
MR304-305
Takeda
Bleed Management in Patients with Inhibitors in the Evolving Treatment Landscape *
11:00 to 11:30
MR304-305
CSL
Shared decision-making for patient-focused haemophilia B management
* This session is for healthcare professionals only.
CRÉDITOS CME
El Congreso Mundial 2026 de la FMH ha sido evaluado y aprobado para su acreditación CME-CPD por la Junta Europea de Acreditación en Hematología (EBAH). La EBAH ha aprobado esta actividad formativa para un máximo de 24,5 créditos CME-CPD. Cada participante solo deberá contabilizar los créditos correspondientes al tiempo que haya dedicado efectivamente a la actividad formativa.
1 hora de actividad de CME-CPD = 1 punto de crédito de EBAH CME-CPD
Se pedirá a los participantes que completen un cuestionario por cada día que estén reclamando créditos, para confirmar su participación en nuestro programa científico.
Los participantes tienen hasta el 7 de mayo de 2026 EST para crear una cuenta en EBAH y completar las encuestas diarias con el fin de obtener créditos de CME. Los participantes podrán imprimir su certificado EBAH-CME a través del sistema EBAH-CME después del 31 de mayo de 2026.
Cuestionarios diarios
Deberás rellenar un cuestionario por cada día por el que desees solicitar créditos.
Los participantes solo deben reclamar créditos por el tiempo realmente dedicado al Congreso Mundial.
Cuenta de EBAH
Para encontrar su número de EBAH-CME, inicie sesión en su cuenta de EBAH (inicio de sesión) o cree una cuenta de EBAH CME si aún no tiene una (crear cuenta).
Crear una cuenta de EBAH CME o iniciar sesión es simple y gratuito.
Por favor, añada su número de cuenta de EBAH CME al/los cuestionario(s).
Dentro del sistema EBAH-CME, usted podrá:
Imprimir sus certificados de EBAH-CME.
Revisar y gestionar su cuenta personal.
Buscar eventos acreditados basados en el Plan de Estudios Europeo de Hematología.
Para obtener más ayuda con su cuenta de EBAH, por favor contacte a:
Oficina de EBAH Koninginnegracht 12b, 2514 AA – La Haya, Países Bajos Teléfono: +31 (0)70 3020 099 Correo-e: [email protected]
El Congreso Mundial 2024 de la FMH abarcará más de 90 horas de sesiones educativas continuas en los segmentos médico y de personas con trastornos de la coagulación (PCTC), así como seis segmentos de desarrollo profesional en los campos de enfermería, odontología, ciencias de laboratorio, aspectos psicosociales, temas musculoesqueléticos (MSK), y mujeres y niñas con trastornos de la coagulación (MNTC). El Congreso Mundial ofrecerá plenarias y sesiones con ponentes destacados, además de sesiones interactivas, talleres, paneles de discusión e innovadores simposios de la industria.
Los períodos de presentación de resúmenes regulares y de última hora han finalizado. Agradecemos a todos los autores que enviaron su investigación al Congreso Mundial de la FMH 2024.
Los autores presentadores que enviaron su resumen durante nuestro período regular de presentación ya han sido notificados sobre su estado de aceptación. Los autores de resúmenes de última hora serán notificados antes del 15 de marzo de 2024.
La FMH desea agradecer a nuestro experto Comité de Revisión de Resúmenes por el tiempo que dedicaron a revisar las presentaciones de resúmenes de 2024. Su contribución en el proceso de revisión imparcial ha permitido a la FMH mantener un alto nivel de calidad para el programa del Congreso Mundial de la FMH 2024.
Habrá hasta 45 presentaciones orales de trabajos libres y 75 presentaciones de posters moderados, además de los más de 300 posters mostrados en nuestras galerías de posters presenciales y virtuales. Para obtener más información sobre nuestras sesiones de trabajos libres y posters moderados, visite nuestro programa completo.
Directrices para posters y presentaciones (solo en inglés)
Los autores presentadores deben descargar y leer cuidadosamente las siguientes directrices antes de preparar y enviar su afiche y/o presentación.
Presentación de trabajos libres
Haz clic en el botón de abajo para acceder a las directrices de presentación de trabajos libres.
Presentación de posters moderados
Haz clic en el botón de abajo para acceder a las directrices de presentación de posters moderados.
Directrices de envío de posters
Haz clic en el botón de abajo para acceder a las directrices de envío de posters.
Paso 1: Cree su perfil e ingrese para tener acceso a la Tarjeta de puntaje de resúmenes.
Paso 2: Complete todas las tareas para someter a consideración su resumen.
Paso 3: Una vez completadas asegúrese de hacer clic en “submit”.
Editar un resumen sometido a consideración
Puede editar su resumen después de haberlo sometido a consideración, hasta el 14 de febrero a las 11:59 p. m. ET, la fecha límite para someter a consideración resúmenes.
Paso 1: Si desea editar su resumen ingrese a la página internet de la Tarjeta de puntaje de resúmenes para tener acceso al(los) resumen(es) que sometió a consideración, donde podrá editarlo(s) actualizando las tareas ya completadas.
Notas importantes:
Los resúmenes solo deberán someterse a consideración a través del sistema en línea. No se tomarán en cuenta resúmenes enviados por correo postal o por correo electrónico.
Solo se tomarán en cuenta resúmenes que hayan sido sometidos a consideración adecuadamente. Los resúmenes incompletos serán rechazados automáticamente.
WFH 2024 World Congress: Abstract categories
Biomedical / coagulation research
Capacity building / advocacy and outreach models
Care delivery
Clinical research and clinical trial
Comorbidities
Data and demographics
Gene therapy
Health policy
Imaging
Infectious complications
Inhibitors
Laboratory issues
New products and novel therapies
Nurses' issues
Oral health
Orthopedic issues
Other
Pain management
Pediatrics
Physiotherapy and rehabilitation
Prophylaxis
Psychosocial issues
Quality of life / outcome research
Rare bleeding disorders
Surgical treatment
Trials in progress
von Willebrand disease
Women and girls' health and research
WFH 2024 World Congress: Late-Breaking Abstract categories
Novel therapies
Case studies demonstrating best practices
Clinical trials (completed)
Clinical trials (in progress)
Evento de networking de posters
Cuándo: lunes 22 de abril – 19:30-20:30 Dónde: Galería de posters dentro del salón de exposiciones
¡Conozca más sobre el trabajo e investigación presentados en nuestra galería de posters, directamente de los autores! Únase a nosotros para una tarde de intercambio de información, fomento de conexiones, generación de conversaciones e inspiración para la colaboración dentro de la comunidad de transtornos de la coagulación.
Someta a consideración su trabajo hoy y únase a miles de destacados expertos a fin de analizar los avances más recientes en el tratamiento y la atención de personas con trastornos de la coagulación.
El Comité de revisión de resúmenes del Congreso Mundial 2024 de la FMH lo conforman profesionales expertos que representan una amplia gama de áreas de especialidad y enfoques científicos.
Fecha límite para enviar posters: 8 de abril de 2024 Fecha límite para enviar diapositivas de PowerPoint para presentaciones de trabajos libres: 17 de abril de 2024
FECHAS IMPORTANTES
Lanzamiento de la convocatoria para presentar resúmenes
15 de septiembre de 2023
Fecha límite para presentar resúmenes
30 de noviembre de 2023, 11:59 p.m. ET
Notificación a los autores
22 de diciembre de 2023
Fecha límite de inscripción de autor(a) presentador(a)
31 de enero de 2024
RESÚMENES DE ÚLTIMO MINUTO
Lanzamiento de la convocatoria para presentar resúmenes de último minuto
17 de enero de 2024
Fecha límite para presentar resúmenes de último minuto
14 de febrero de 2024, 11:59 p.m. ET
Notificación a los autores
15 de marzo de 2024
Fecha límite de inscripción de autor(a) presentador(a)
Fechas y horarios de publicación de resúmenes (Embargo)
Los resúmenes de último minuto se publicarán durante el Congreso Mundial de la FMH 2024. A continuación, se detallan las fechas de embargo y el calendario de publicación de los resúmenes de último minuto.
Todos los demás resúmenes, incluidos los enviados durante el período de presentación tardía pero no seleccionados como resúmenes de último minuto, se publicarán a las 9:00 am CEST del 21 de abril de 2024 y estarán disponibles en línea.
El Congreso Mundial será el evento internacional más completo sobre trastornos de la coagulación en 2024. Los autores presentadores pueden esperar compartir sus trabajos entre destacados expertos e investigadores de todo el mundo.
Los resúmenes seleccionados serán elegibles para lo siguiente:
Exhibición en la galería virtual de posters – Disponible en línea por 60 días.
Publicación en Haemophilia, el periódico oficial de la FMH.
Presentación oral en una sesión de artículos libres.
Presentación en rondas relámpago durante una sesión de posters moderada.
Poster impreso y presentación durante el evento para establecer contactos y los descansos.
Candidatura al Premio Christine Lee para investigadores jóvenes por la mejor presentación oral.
Candidatura al Premio Christine Lee para investigadores jóvenes por la mejor presentación de un poster. – Nuevo este año!
Candidatura a premios de viaje por resumen destacado. – Nuevo este año!
El periodo para someter a consideración resúmenes de último minuto es del 17 de enero al 14 de febrero de 2024.
Los resúmenes de último minuto deben describir avances innovadores que modificarán el ejercicio diario de la medicina y deben destacar estudios novedosos y que modifiquen la práctica. El proceso de selección favorecerá resúmenes con datos innovadores y únicos que de otro modo no habrían podido presentarse durante el Congreso. En todos los casos, los resultados no deberían haber estado disponibles en la fecha límite para someter a consideración resúmenes normales.
Fechas y horarios de publicación de resúmenes (Embargo)
Los resúmenes de último minuto se publicarán durante el Congreso Mundial de la FMH 2024. A continuación, se detallan las fechas de embargo y el calendario de publicación de los resúmenes de último minuto.
Todos los demás resúmenes, incluidos los enviados durante el período de presentación tardía pero no seleccionados como resúmenes de último minuto, se publicarán a las 9:00 am CEST del 21 de abril de 2024 y estarán disponibles en línea.
El Comité de revisión de resúmenes del Congreso Mundial 2024 de la FMH lo conforman profesionales expertos que representan una amplia gama de áreas de especialidad y enfoques científicos.
HAEMOPHILIA SUPPLEMENTS
WFH 2024 State of the Art Book
This peer reviewed supplement reflects the best clinical practice advice and expert opinion within the various subspecialties of bleeding disorders and related fields that will be presented in the scientific program of the WFH 2024 World Congress.
Plan your calendar for free paper sessions, moderated poster presentations, and a comprehensive poster gallery, all showcasing the research and work presented on the abstracts of the WFH 2024 World Congress.
Establecidos en 2012 por la Federación Mundial de Hemofilia (FMH) y Wiley, el Premio Christine Lee para investigadores jóvenes (anteriormente Premio Christine Lee del periódico Haemophilia) se otorga como reconocimiento a un(a) investigador(a) joven destacado(a) (estudiante de posgrado o becario(a) posdoctoral) que sea el(la) principal autor(a) y presentador(a) de un resumen altamente calificado en cualquier disciplina relacionada con la hemofilia u otros trastornos de la coagulación similares.
Mejor presentación oral
Este premio otorga US$ 3,000 y una suscripción personal de tres años al periódico Haemophilia.
Mejor presentación de poster
Este premio otorga US$ 1,000 y una suscripción personal de tres años al periódico Haemophilia.
Elegibilidad
El comité de selección, conformado por los editores del periódico y representantes de la FMH en el consejo editorial, elegirá los resúmenes mejor presentados durante el Congreso Mundial 2024 de la FMH. Habrá un receptor por premio.
El(la) investigador(a) joven deberá ser menor de 40 años al momento de someter a consideración el resumen. En el caso de autores múltiples, el(la) autor(a) principal y presentador(a) deberá ser menor de 40 años al momento de someter a consideración el resumen.
Premios de viaje a resúmenes destacados
La FMH tiene el gusto de ofrecer cinco (5) subvenciones de US$ 1,000 cada una a los cinco (5) resúmenes sometidos a consideración para el Congreso Mundial 2024 de la FMH que obtengan los puntajes más altos.
Al someter a consideración su resumen indique si desea ser considerado(a) para un premio de viaje. Si tuviera acceso a una fuente de financiamiento alterna agradeceremos darle prioridad a esta a fin de permitir que el mayor número posible de asistentes reciba el beneficio de los premios de viaje de la FMH.
PREGUNTAS FRECUENTES SOBRE CÓMO SOMETER A CONSIDERACIÓN RESÚMENES
P
¿Qué tan largo debería ser mi resumen?
R
Su resumen no debería tener más de 350 palabras. Esta cifra no incluye datos del autor, títulos, cuadros y gráficas.
P
¿Puedo incluir cuadros/gráficas en mi resumen?
R
Puede incluirse un máximo de dos cuadros y/o gráficas en un resumen. Asegúrese de agregar encabezados a cada uno de los cuadros y/o gráficas, y de hacer referencia a los mismos en el resumen. No incluya la lista de autores en la figura/cuadro que someta a consideración dado que el método de revisión es ciego.
P
¿Cuántos resúmenes puedo someter a consideración?
R
No hay un límite para el número de resúmenes que puede someter a consideración un solo autor.
P
¿Cuántos resúmenes puedo presentar?
R
Cada autor presentador puede presentar un máximo de dos resúmenes en el Congreso. Si se aceptaran más de dos resúmenes de un autor deberá designarse a un coautor como autor presentador para el tercer o los demás resúmenes.
P
¿Puedo someter a consideración mi resumen por correo electrónico?
R
No. Los resúmenes solo deberán someterse a consideración mediante el sistema de presentación en línea. No se aceptarán resúmenes enviados por correo electrónico.
P
¿Puedo someter a consideración un resumen en otro idioma que no sea inglés?
R
No. Solo se aceptarán resúmenes sometidos a consideración en inglés. Los resúmenes en otro idioma que no sea inglés se rechazarán automáticamente.
P
¿Cuántos autores pueden enumerarse para cada resumen?
R
Se permite un máximo de 20 autores por resumen.
P
¿Puedo editar/modificar mi resumen?
R
Pueden hacerse correcciones hasta el día de la nueva fecha límite para someter a consideración resúmenes, que es el 14 de febrero a las 11:59 p. m. ET. Porfavor envie un correo a [email protected] si usted sometió a consideracion un resumen antes de la fecha límite original del 15 de noviembre de 2023. A fin de garantizar la integridad del proceso de revisión no se aceptarán correcciones después de la nueva fecha limite.
P
¿Puedo someter a consideración el resumen de un ensayo en curso?
R
Sí. La FMH aceptará resúmenes de ensayos en curso. Si desea más información consulte las guías para someter a consideración resúmenes.
P
¿Puede un administrador/un tercero someter a consideración un resumen en nombre de los autores?
R
Sí. No obstante, sírvase notar que, si el resumen fuera aceptado, toda la correspondencia y notificaciones subsecuentes se enviarán al autor presentador.
P
¿Cuándo sabré si mi resumen fue aceptado?
R
Se le notificará si su resumen fue o no aceptado a más tardar el 22 de diciembre de 2023. Se le notificará si su resumen de último minuto fue o no aceptado a más tardar el 15 de marzo de 2024.
P
¿Necesito inscribirme para asistir al Congreso Mundial?
R
Si. Todos los autores que sometan a consideración resúmenes de último minuto deberán inscribirse a más tardar el 31 de marzo de 2024 para asistir al Congreso Mundial 2024 de la FMH. Después de esta fecha, los autores presentadores que no se hayan inscrito y pagado su cuota de inscripción serán excluidos del programa, así como de la publicación en el periódico Haemophilia. No se dispensará el pago de la cuota de inscripción.
P
¿Puedo hacer una presentación virtual?
R
No. El Congreso Mundial 2024 de la FMH tendrá lugar exclusivamente en persona. Por tanto, se requiere que los autores presentadores se encuentren presentes en Madrid, España.
P
¿Cuándo se publicará mi resumen aceptado?
R
Los resúmenes seleccionados para su publicación estarán disponibles en la edición en línea del periódico Haemophilia del 21 de abril de 2024. La publicación estará disponible en la página internet de Wiley, en la página internet del Congreso Mundial 2024 de la FMH, y en la aplicación móvil del Congreso. Los resúmenes de último minuto seleccionados para su publicación estarán disponibles después del Congreso. Pronto habrá más información disponible
P
¿Aceptará la FMH resúmenes de último minuto?
R
Sí. La convocatoria para someter a consideración resúmenes de último minuto se abrirá el 17 de enero de 2024 y se cerrará el 14 de febrero de 2024.
The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.
While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.
Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.
References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.
Fraud Alert
Unauthorized solicitations – Warning
The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.
If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).
We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.
Hemophilia Alliance
Recognizing that training women leaders ensures the diversity our community need to thrive; the Hemophilia Alliance has been a longtime supporter of the Susan Skinner Memorial Fund. They deepened their engagement with the global community through the establishment of the Travel Grant Program, which allows US-based multidisciplinary healthcare professionals the opportunity to attend WFH global training workshops. The wealth of experience and perspective attendees bring back home to their communities helps patients across the country. Their patience and support as we grappled with changing norms in these challenging times gave us the flexibility to meet our community’s needs with revamped programming.
Hemophilia of Georgia
Hemophilia of Georgia has stood with us for over three decades, playing an early role in distributing donated factor via the WFH Humanitarian Aid program. Our relationship has deepened over the years as they continued to support this program and came on board as a founding Chapter Challenge champion in 2016. Their belief in educating future leaders is clear in their investment in the Youth Leadership Workshops, which has led to the training of over 50 young adults. They also support workshops devoted to educating providers and patient leaders on how to collect and use data to advocate for better patient care. Their staff generously volunteer their time as trainers and as well as serving on various committees.
National Bleeding Disorders Foundation
The National Bleeding Disorders Foundation helps advance our mission on several fronts. They inspire others to follow their lead as a founding champion of the NHF Chapter Challenge. Their commitment to equality of access is demonstrated in their support of the Cornerstone Initiative, which lays the foundation for care in the world's most underserved regions, as well as programs that aim to raise awareness and improve care of women with bleeding disorders and those with von Willebrand disease. We also benefit from their steadfast engagement with various programs including the WFH Twinning Program and their individual leaders’ contribution to our leadership and committees.
Legacy Gift
Do you sometimes wish you could do more? A bequest is a simple way for you to make a significant gift without changing anything about your financial security and lifestyle today. Your legacy will sustain care for the generations to come.
Download these sample clauses to give to your legal advisor.
We understand if you prefer to remain anonymous, but we would be very honoured if you would let us know of your intentions so that we may thank you personally. We would also be happy to answer any questions you may have or give you additional information. Please contact Jennifer Laliberté at 514‑875‑7944 ext.2822 or [email protected].
Disclaimer
The information on the WFH USA website is provided for general information purposes only. The WFH USA does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH USA recommends that you contact your physician or local treatment centre. Before administering any products, the WFH USA urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.
While every effort has been made to ensure the accuracy of the information on this site, the WFH USA does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.
Messages posted to WFH USA discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH USA social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH USA recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.
References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH USA. The WFH USA is not responsible and assumes no liability for the content of any linked websites.
Website privacy policy
The WFH USA does not collect personally identifying information about you when you visit our site, unless you choose to provide such information to us. Providing such information is strictly voluntary. This policy is your guide to how we will handle information we learn about you from your visit to our website.
Use of links
Throughout our website, we provide links to other servers which may contain information of interest to our readers. We take no responsibility for, and exercise no control over, the organizations, views, or accuracy of the information contained on other servers. When linking to the WFH USA, we request that you ensure that there are no associated connections for commercial purposes. Any official use of the name WFH USA or the use of its logo needs to be approved by the WFH USA. If you have a link you’d like us to consider adding to our website, please send an email to [email protected] with the subject “Link request.”
Use of text and images
All information, photographs, graphics, and other material on this website are protected by copyright. While users of this website may use the content for personal, non-commercial use, none of the content of this website can be modified, translated, transferred or sold, copied, reproduced, published, or distributed, in whole or in part, without the prior written consent of the WFH USA. To view a copy of the WFH USA’s permissions guidelines, click here.
The WFH USA encourages the dissemination of its information and welcomes proposals on the reprinting, redistribution, and translation of its materials. If you would like to publish information that you find on our website, please send your request to [email protected].
Accessibility
If you have suggestions on how to make the site more accessible, please contact us at [email protected].
Opt-Out or Change Your Contact Information
Our website provides users the opportunity to opt-out of receiving communications from us through a special online form or via the communication they have received. You may, at all times, choose to receive which communications within the organization you can receive or none at all. You may also update your contact information previously provided to us via another online form.
Questions about our policies
If you have any questions about this privacy statement, the practices of this site, or your dealings with this website, you can contact us at [email protected].
Fraud alert
Unauthorized solicitations – Warning
The WFH USA has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH USA staff or falsely stating that they are associated with the WFH USA. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH USA, are fraudulent and come from outside of our organization.
If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH USA emails come from @wfhusa.org or @wfh.org).
We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH USA at [email protected] or call 1-877-417-7944.
Premio internacional de la FMH por servicios destacados - receptores
Premio internacional de la FMH al voluntariado por la atención de la salud - receptores
AÑOS PASADOS
2012
Piet de Kleijn Países Bajos
2010
Dr. Mammen Chandy India
2008
Dr. Man-Chiu Poon Canadá
2006
Dr. Norma de Bosch Venezuela
2004
Dr. Parttraporn Insarangkura Tailandia
Dr. Carol K. Kasper Estados Unidos
Premios a los hermanamientos del año
2022
Ammán (Jordania) – Dublín (Irlanda)
2021
Addis Abeba (Etiopía) – Minneapolis (EE.UU.) y Teherán (Irán) – Milán (Italia)
2020
Aluva (India) – Newcastle (Reino Unido)
2019
Yogyakarta / Solo (Indonesia) – Utrecht (Países Bajos)
2018
Abidjan (Costa de Marfil) – Bruselas (Bélgica)
2017
Santa Cruz de la Sierra (Bolivia) – Buenos Aires (Argentina)
2016
Kampala (Uganda) – Londres (Reino Unido)
2015
Varna (Bulgaria) – Bonn (Alemania)
2014
Arequipa (Perú) – Los Ángeles (Estados Unidos)
2013
Davangere (India) – Liverpool (Reino Unido)
Ludhiana (India) – Detroit (Estados Unidos)
Georgia – Minnesota (Estados Unidos)
Uruguay – Argentina
1999
Nepal – Suecia México - Texas (Estados Unidos)
1998
Letonia – Alemania
1997
India – Dinamarca
1995
Israel – Eslovaquia
Premio Pietrogrande
2025
Greig Blamey Canadá
2023
Nicholas Goddard Reino Unido
2021
Axel Seuser Alemania
2019
Dr. Adolfo Llinás Colombia
2017
Pamela Hilliard Canadá
2015
Kathy Mulder Canadá
2013
James Luck Estados Unidos
2012
Piet de Kleijn Países Bajos
2011
Dr. Lily Heijnen Países Bajos
2010
Dr. Horacio Caviglia Argentina
2009
Jerome D. Wiedel Estados Unidos
2008
Dr. Federico Fernández-Palazzi Venezuela
2007
Michael Heim Israel
2006
Brenda Buzzard Reino Unido
2005
Dr. Marvin Gilbert Estados Unidos
Premio Henri Horoszowski
2025
Shubhranshu S. Mohanty India
Haemophilic pseudotumour – New improvised classification system and its outcome in 168 cases at a Tertiary care centre
2021
Baolai Hua China
The effects of intra-articular injection of TNF-alpha Antagonists in treatment of haemophilic synovitis
2019
Maarten Eerdekens Bélgica
Asociación entre la cinética multisegmento del pie y el daño articular inducido por la sangre en pacientes adultos con artropatía hemofílica del tobillo
2017
Fabio Souza Brasil
Decrease in joint inflammation, swelling and pain after a swimming protocol in animal model of experimental-induced hemarthrosis
2015
SM Javd Mortazavi Irán
Bilateral total knee arthroplasty in patients with hemophilia: A safe and cost-effective procedure
2013
Lize F.D. van Vulpen Estados Unidos
Una proteína de fusión de IL4 e IL10 es igualmente eficaz para proteger el cartílago del daño inducido por la sangre en comparación con los componentes
2012
Horacio Caviglia Argentina
Cirugía de pseudotumor en pacientes con hemofilia A: resultados comparativos entre pacientes inhibidores y no inhibidores
2011
Nick Goddard Reino Unido y Monique van Meegeren Países Bajos
La administración temprana de IL-4 e IL-10 previene el daño del cartílago inducido por la sangre in vitro
2010
Lydia Abad-Franch España
Influencia de un protocolo de entrenamiento acuático en la reducción del riesgo de morbilidad y mortalidad cardiovascular en un hemofílico
2009
Sebastien Lobet Bélgica
Impacto de la artropatía del tobillo con hemofilia en la discapacidad de la marcha: análisis de variables energéticas y mecánicas
2008
Jose Alberto Tlacuilo-Parra México
Marcadores de rotación ósea y densidad mineral ósea en niños con hemofilia
2007
Natalie Jansen Países Bajos
Capacidades protectoras de la interleucina-10 en el daño del cartílago inducido por la sangre
2006
Axel Seuser y E. Kusch Alemania
Estudio multicéntrico del resultado ortopédico de las extremidades inferiores en 249 niños con hemofilia
2005
Frank van Genderen, Nico van Meeteren, Lily Heijnen, Piet de Kleijn, Marijke van den Berg, Paul Helders Países Bajos
Lista de actividades para la hemofilia: desarrollo final y validación de un cuestionario de autoevaluación específico para hemofilia sobre las capacidades funcionales
2004
Goris Roosendaal, Zalima N Jahangier, Kim MG Jacobs, Johannes WJ Bijlsma, Floris PJG Lafeber Países Bajos
La radiosinoviortesis con YTTRIUM-90 da como resultado efectos directos adversos sobre el cartílago: un estudio in vitro en humanos
2003
Axel Seuser, Thomas Wallny, Günter Schumpe, Elmar Trunz, Hans-Hermann Brackman Alemania
¿Cómo aconsejar a los jóvenes hemofílicos que encuentren el deporte adecuado? Un algoritmo nuevo y seguro
2002
James Luck, Jr. y Mauricio Silva Estados Unidos
Revisión a largo plazo de la artroplastia total de rodilla
2001
Federico Fernández-Palazzi Venezuela
Clorhidrato de oxitetraciclina: un nuevo material para las órtesis sinoviales químicas
2000
Horacio Caviglia Argentina
Pseudotumores
1999
William J. Ribbans y J.L. Hicks Reino Unido
Comunicación y cooperación para el nuevo milenio: el futuro del comité musculoesquelético en el siglo XXI
1998
Adolfo Llinas, Mauricio Silva, Monica Duarte, Gonzalo Ucros, Graciela Perini, Angela Maria Cerquera, Andres Forero Colombia
La sinoviortesis de fosfato crómico sin restricción de edad debería ser la primera opción de tratamiento para la sinovitis hemofílica activa crónica
Escalas funcionales
Los resultados de interés recolectados en el RMTC abarcan características demográficas, resultados médicos y relacionados con el tratamiento, resultados de la carga de la enfermedad, y resultados reportados por los pacientes.
El RMTC incluye cinco escalas funcionales (en inglés) como parte de su conjunto de datos ampliados:
El conjunto de datos mínimo (CDM) es un grupo de datos demográficos, sobre diagnóstico, síntomas y tratamiento que se recolecta de los pacientes que participan en el RMTC.
Conjunto de datos ampliado del RMTC
El conjunto de datos ampliado (CDA)es un grupo de datos más grande, con mayores detalles que el CDM, que abarca preguntas sobre datos demográficos, diagnóstico, síntomas, tratamiento y carga de la enfermedad de los pacientes. Los centros de tratamiento de hemofilia pueden utilizar el CDA para recolectar información de pacientes que participan en el RMTC. El conjunto de datos ampliado (CDA) del RMTC se agregó a la base de datos en marzo del 2019.
Estados Unidos - Columbus, Ohio
Año de designación del CIEHEMO: 2018
Nationwide Children’s Hospital
Áreas de especialidad
Cuidados dentales
Diagnóstico de laboratorio
Enfermería
Cirugía y cuidados ortopédicos
Servicios de hematología pediátrica
Fisioterapia/Terapia ocupacional
Psicología/Servicios sociales
Estados Unidos - Houston, Texas
Año de designación del CIEHEMO: 2000
Gulf States Hemophilia and Thrombophilia Center University of Texas Health Science Center at Houston
Áreas de especialidad
Hematología pediátrica y adultos
Diagnóstico de laboratorio y hemostasia
Enfermería
Banco de sangre
Fisioterapia/Terapia ocupacional
Psicología/Servicios sociales
Estados Unidos - Los Ángeles, California
Año de designación del CIEHEMO: 1970
Lifespan Orthopaedic Hemophilia Treatment Center at Luskin Orthopedic Institute for Children
Áreas de especialidad
Hematología pediátrica y adultos
Diagnóstico de laboratorio y hemostasia
Enfermería
Cirugía y cuidados ortopédicos
Fisioterapia
Psicología/Servicios sociales
Estados Unidos – Nueva York, Nueva York
Año de designación del CIEHEMO: 1993
Mount Sinai School of Medicine Mount Sinai Medical Center
Áreas de especialidad
Hematología pediátrica y adultos
Diagnóstico de laboratorio y hemostasia
Enfermería
Cirugía y cuidados ortopédicos
Genética molecular
Servicios sociales
Estados Unidos - Rochester, Minnesota
Año de designación del CIEHEMO: 1974
Mayo (Rochester) Comprehensive Hemophilia Center, and International Hemophilia Training Center (WFH) Mayo Clinic/Foundation and Mayo Medical School
Áreas de especialidad
Hematología pediátrica y adultos
Banco de sangre
Diagnóstico de laboratorio y hemostasia
Genética molecular
Enfermería
Cirugía y cuidados ortopédicos
Fisioterapia
Psicología/Servicios sociales
Estados Unidos - San Diego, California
Año de designación del CIEHEMO: 2018
Hemophilia & Thrombosis Treatment Center University of California San Diego
Áreas de especialidad
Hematología adultos
Fisioterapia/Terapia ocupacional
Cuidados dentales
Cuidados ortopédicos (sin cirugía)
Diagnóstico de laboratorio
Enfermería
Psicología/Servicios sociales
Reino Unido – Londres
Año de designación del CIEHEMO: 1970
Katharine Dormandy Haemophilia Centre and Thrombosis Unit Royal Free Hospital
Áreas de especialidad
Hematología adultos
Diagnóstico de laboratorio y hemostasia
Enfermería
Cirugía y cuidados ortopédicos
Fisioterapia/Terapia ocupacional
Genética molecular
Psicología/Servicios sociales
Reino Unido – Oxford
Año de designación del CIEHEMO: 1972
Oxford Haemophilia and Thrombosis Centre Churchill Hospital
Áreas de especialidad
Hematología pediátrica y adultos
Diagnóstico de laboratorio y hemostasia
Cirugía y cuidados ortopédicos
Enfermería
Genética molecular
Fisioterapia/Terapia ocupacional
Psicología y servicios sociales
Reino Unido - Sheffield
Año de designación del CIEHEMO: 1992
Sheffield Haemophilia and Thrombosis Centre Royal Hallamshire Hospital
Áreas de especialidad
Hematología adultos
Diagnóstico de laboratorio y hemostasia
Genética molecular
Tailandia - Bangkok
Año de designación del CIEHEMO: 1984
International Hemophilia Training Center – Bangkok Ramathibodi Hospital Mahidol University
Áreas de especialidad
Hematología pediátrica y adultos
Banco de sangre
Cuidados y cirugía dentales
Diagnóstico de laboratorio y hemostasia
Enfermería
Cirugía y cuidados ortopédicos
Fisioterapia
Psicología y servicios sociales
Suecia - Malmö
Año de designación del CIEHEMO: 1976
Malmö Centre for Thrombosis and Haemostasis Department for Hematology and Coagulation Disorders, Skåne University Hospital Skåne University Hospital
Áreas de especialidad
Hematología pediátrica y adultos
Banco de sangre (a pedido)
Cuidados y cirugía dentales
Diagnóstico de laboratorio y genética
Enfermería
Cirugía y cuidados ortopédicos
Fisioterapia
España - Madrid
Año de designación del CIEHEMO: 2018
Hospital Universitario La Paz
Áreas de especialidad
Hematología pediátrica y adultos
Fisioterapia/Terapia ocupacional
Cuidados dentales
Cuidados ortopédicos (sin cirugía)
Diagnóstico de laboratorio
Enfermería
Psicología/Servicios sociales
España - Valencia
Año de designación del CIEHEMO: 1997
Haemostasis and Thrombosis Unit Haematology Service, University and Polytechnic Hospital
Áreas de especialidad
Hematología pediátrica y adultos
Diagnóstico de laboratorio y hemostasia
Genética molecular
Enfermería
Cirugía y cuidados ortopédicos
Fisioterapia
Banco de sangre
Psicología y servicios sociales
Sudáfrica - Johannesburgo
Año de designación del CIEHEMO: 2016
Haemophilia Comprehensive Care Centre Charlotte Maxeke Johannesburg Academic Hospital
Áreas de especialidad
Hematología pediátrica y adultos
Cuidados dentales
Diagnóstico de laboratorio y hemostasia
Enfermería
Cirugía ortopédica
Fisioterapia
Singapur - Singapur
Año de designación del CIEHEMO: 2002
Singapore General Hospital Haemophilia Treatment Clinic
Áreas de especialidad
Hematología adultos
Diagnóstico de laboratorio
Enfermería
Cuidados dentales
Cuidados ortopédicos (sin cirugía)
Fisioterapia
Psicología
Senegal - Dakar
Año de designación del CIEHEMO: 2016
Centre International de Traitement de l’Hémophilie (CITH) de Dakar Centre National de Transfusion Sanguin (CNTS)
Áreas de especialidad
Hematología pediátrica y adultos
Diagnóstico de laboratorio y hemostasia
Enfermería
Banco de sangre
Fisioterapia
Rusia – Moscú y San Petersburgo
Año de designación del CIEHEMO: 2010
National Medical Research Center of Hematology of the Russian Academy of Medical Sciences
Áreas de especialidad
Hematología adultos
Enfermería
Cirugía ortopédica
Países Bajos - Utrecht
Año de designación del CIEHEMO: 1996
Van Creveldkliniek University Medical Centre Utrecht
Áreas de especialidad
Hematología pediátrica y adultos
Diagnóstico de laboratorio y hematología
Enfermería
Cirugía y cuidados ortopédicos
Fisioterapia/Terapia ocupacional
Psicología y servicios sociales
Japón - Nara
Año de designación del CIEHEMO: 1998
Nara Hemophilia Centre Nara Medical University
Áreas de especialidad
Hematología pediátrica y adultos
Cuidados dentales
Diagnóstico de laboratorio y genética molecular
Enfermería
Cirugía y cuidados ortopédicos
Fisioterapia
Italia - Milán
Año de designación del CIEHEMO: 1972
Angelo Bianchi Bonomi Hemophilia and Thrombosis Centre Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico
Áreas de especialidad
Hematología pediátrica y adultos
Banco de sangre
Cuidados dentales
Valoración diagnóstica de defectos de la función plaquetaria
Diagnóstico de laboratorio y hemostasia
Genética molecular
Enfermería
Cirugía y cuidados ortopédicos
Fisioterapia
Psicología y servicios sociales
Israel - Tel Hashomer
Año de designación del CIEHEMO: 1993
National Hemophilia Center, Tel Hashomer Sheba Medical Center
Áreas de especialidad
Hematología pediátrica y adultos
Cirugía ortopédica
Enfermería
Fisioterapia
Cuidados dentales
Diagnóstico de laboratorio (sin genética)
Psicología
India - Mumbai
Año de designación del CIEHEMO: 2000
National Institute of Immunohaematology (ICMR) and KEM Hospital
Áreas de especialidad
Hematología pediátrica y adultos
Diagnóstico de laboratorio y hemostasia
Genética molecular
Cuidados dentales
Enfermería
Cuidados ortopédicos
Fisioterapia
India - Vellore
Año de designación del CIEHEMO: 2000
Christian Medical College, Vellore
Áreas de especialidad
Hematología pediátrica y adultos
Diagnóstico de laboratorio y hemostasia
Genética molecular con diagnóstico prenatal
Enfermería
Manejo musculoesquelético – Terapia física y ocupacional con fisiatría
Cirugía y cuidados ortopédicos
Banco de sangre
Cuidados dentales
Psicología/Servicios sociales
Diagnóstico prenatal
París - Francia
Año de designación del CIEHEMO: 1972
Paris Haemophilia Centre (Necker (N) and Kremlin Bicêtre (KB) Hospitals)
Áreas de especialidad
Hematología pediátrica y adultos
Diagnóstico de laboratorio y hemostasia
Enfermería
Cuidados dentales
Cirugía y cuidados ortopédicos
Fisioterapia
Psicología y servicios sociales
Egipto – El Cairo
Año de designación del CIEHEMO: 2015
Shabrawishi Hospital, Egyptian Society of Hemophilia, and Cairo University
Áreas de especialidad
Hematología pediátrica y adultos
Diagnóstico de laboratorio y hemostasia
Enfermería
Genética molecular
Banco de sangre
Fisioterapia
Canadá - Toronto
Año de designación del CIEHEMO: 2018
University of Toronto Hemophilia Centres St. Michael’s Hospital
Áreas de especialidad
Servicios hematológicos para adultos
Servicios de hematología pediátrica
Fisioterapia/Terapia ocupacional
Cuidados dentales
Cuidados ortopédicos (sin cirugía)
Diagnóstico de laboratorio
Enfermería
Psicología/Servicios sociales
Brasil - Campinas, SP
Año de designación del CIEHEMO: 2008
Hemocentro – “Unidade de Hemofilia Cláudio Luiz Pizzigatti Corrêa” Hemocentro Unicamp, University of Campinas
Áreas de especialidad
Hematología pediátrica y adultos
Diagnóstico de laboratorio y genética molecular
Enfermería
Odontología
Cirugía y cuidados ortopédicos
Fisioterapia
Bélgica - Bruselas
Año de designación del CIEHEMO: 2013
Haemostasis and Thrombosis Unit Division of Haematology Cliniques universitaires Saint-Luc
Áreas de especialidad
Hematología pediátrica y adultos
Diagnóstico de laboratorio
Cirugía y cuidados ortopédicos
Fisioterapia
Austria - Viena
Año de designación del CIEHEMO: 1972
Medical University of Vienna Department of Medicine I Clinical Division of Hematology and Hemostaseology
Áreas de especialidad
Hematología pediátrica y adultos
Australia - Melbourne
Año de designación del CIEHEMO: 2005
Ronald Sawers Haemophilia Treatment Centre
Áreas de especialidad
Hematología adultos
Diagnóstico de laboratorio y hemostasia
Cirugía y cuidados ortopédicos
Enfermería
Cuidados dentales
Banco de sangre
Psicología
Trabajo social
Argentina - Buenos Aires
Año de designación del CIEHEMO: 1974
Instituto Asistencial “Dr. Alfredo Pavlovsky” (Fundación de la Hemofilia)
Instituto De Investigaciones Hematológicas “Dr. Mariano R. Castex” (IIHEMA (Academia Nacional de Medicina)
Áreas de especialidad
Hematología pediátrica y adultos
Fisioterapia
Cuidados dntales
Cirugía y cuidados ortopédicos
Diagnóstico de laboratorio y diagnóstico genético
Enfermería
Psicología
Servicios sociales
Nuestra historia
Frank Schnabel, un hombre de negocios canadiense con hemofilia A grave, fundó la FMH en 1963. Schnabel estaba convencido de que las organizaciones de pacientes podían ser mucho más eficaces, y hacer más para representar los intereses de las personas con trastornos de la coagulación, si trabajaban unidas. El primer Congreso de la FMH se realizó en Copenhague, Dinamarca, el 25 de junio de 1963, y en él participaron representantes de 12 países. Actualmente, la FMH y su red mundial de organizaciones nacionales miembros (ONM) representan los intereses de personas con hemofilia y otros trastornos de la coagulación hereditarios en 151 naciones.
Ceremonia de inauguración & Recepción de bienvenida
Abril 19|18:30 – 21:30
La ceremonia de inauguración dará oficialmente el pistoletazo de salida al Congreso Mundial 2026 de la FMH, reuniendo a todos los asistentes para celebrar el inicio del congreso. La velada continuará con la recepción de bienvenida, que ofrecerá a los participantes la oportunidad de relacionarse, establecer contactos e interactuar con colegas de todo el mundo.
Precio: 20 USD para profesionales sanitarios, 55 USD para invitados; gratuito para el resto de delegados.
Sesión de pósteres y networking
Abril 20|18:00
Acompáñenos el 20 de abril, fecha en la que se realizará el evento para establecer contactos durante la presentación de posters, el cual ofrecerá a presentadores y asistentes la oportunidad de conocerse, explorar nuevas investigaciones e intercambiar perspectivas sobre los acontecimientos más recientes en el campo de los trastornos de la coagulación.
Costo: Incluido para todos los delegados